536MO A phase I, first-in-human, safety, pharmacokinetic, and pharmacodynamic study of oral dubermatinib (TP-0903) in patients with advanced solid tumours.
Saved in:
| Title: | 536MO A phase I, first-in-human, safety, pharmacokinetic, and pharmacodynamic study of oral dubermatinib (TP-0903) in patients with advanced solid tumours. |
|---|---|
| Authors: | Adjei, A.A.1 (AUTHOR), Beg, M.2 (AUTHOR), Melear, J.3 (AUTHOR), Thompson, J.4 (AUTHOR), Tsai, F.Y-C.5 (AUTHOR), Baranda, J.C.6 (AUTHOR), Bastos, B.7 (AUTHOR), Spira, A.8 (AUTHOR), Lou, Y.9 (AUTHOR), Seetharam, M.10 (AUTHOR), Uemura, M.11 (AUTHOR), Camidge, D.R.12 (AUTHOR), Yamamoto, N.13 (AUTHOR), Cowey, C.L.14 (AUTHOR), Doi, T.15 (AUTHOR), Anthony, S.P.16 (AUTHOR), Janat-Amsbury, M.17 (AUTHOR), Wade, M.18 (AUTHOR), Bearss, D.J.19 (AUTHOR), Sarantopoulos, J.20 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS469-S469. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152695229 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 536MO A phase I, first-in-human, safety, pharmacokinetic, and pharmacodynamic study of oral dubermatinib (TP-0903) in patients with advanced solid tumours. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Adjei%2C+A%2EA%2E%22">Adjei, A.A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beg%2C+M%2E%22">Beg, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Melear%2C+J%2E%22">Melear, J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thompson%2C+J%2E%22">Thompson, J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tsai%2C+F%2EY-C%2E%22">Tsai, F.Y-C.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baranda%2C+J%2EC%2E%22">Baranda, J.C.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bastos%2C+B%2E%22">Bastos, B.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spira%2C+A%2E%22">Spira, A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lou%2C+Y%2E%22">Lou, Y.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Seetharam%2C+M%2E%22">Seetharam, M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Uemura%2C+M%2E%22">Uemura, M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Camidge%2C+D%2ER%2E%22">Camidge, D.R.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yamamoto%2C+N%2E%22">Yamamoto, N.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cowey%2C+C%2EL%2E%22">Cowey, C.L.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Doi%2C+T%2E%22">Doi, T.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Anthony%2C+S%2EP%2E%22">Anthony, S.P.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Janat-Amsbury%2C+M%2E%22">Janat-Amsbury, M.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wade%2C+M%2E%22">Wade, M.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bearss%2C+D%2EJ%2E%22">Bearss, D.J.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sarantopoulos%2C+J%2E%22">Sarantopoulos, J.</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS469-S469. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152695229 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.650 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S469 Titles: – TitleFull: 536MO A phase I, first-in-human, safety, pharmacokinetic, and pharmacodynamic study of oral dubermatinib (TP-0903) in patients with advanced solid tumours. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Adjei, A.A. – PersonEntity: Name: NameFull: Beg, M. – PersonEntity: Name: NameFull: Melear, J. – PersonEntity: Name: NameFull: Thompson, J. – PersonEntity: Name: NameFull: Tsai, F.Y-C. – PersonEntity: Name: NameFull: Baranda, J.C. – PersonEntity: Name: NameFull: Bastos, B. – PersonEntity: Name: NameFull: Spira, A. – PersonEntity: Name: NameFull: Lou, Y. – PersonEntity: Name: NameFull: Seetharam, M. – PersonEntity: Name: NameFull: Uemura, M. – PersonEntity: Name: NameFull: Camidge, D.R. – PersonEntity: Name: NameFull: Yamamoto, N. – PersonEntity: Name: NameFull: Cowey, C.L. – PersonEntity: Name: NameFull: Doi, T. – PersonEntity: Name: NameFull: Anthony, S.P. – PersonEntity: Name: NameFull: Janat-Amsbury, M. – PersonEntity: Name: NameFull: Wade, M. – PersonEntity: Name: NameFull: Bearss, D.J. – PersonEntity: Name: NameFull: Sarantopoulos, J. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2020 Supplement 4 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
